Early initiation of low-dose hydrocortisone treatment for septic shock in adults: A randomized clinical trial

American Journal of Emergency Medicine

Volumn 35, Issue 12, 2017, Pages 1810-1814

  Lv, Qing quan ^a   Gu, Xiao hua ^a   Chen, Qi hong ^a   Yu, Jiang quan ^a   Zheng, Rui qiang ^a  

^a YANGZHOU UNIVERSITY   (China)

Author keywords

Hydrocortisone; Mortality; Septic shock

Indexed keywords

ANTIBIOTIC AGENT; DOBUTAMINE; HYDROCORTISONE; HYPERTENSIVE FACTOR; NORADRENALIN; PLACEBO; ANTIINFLAMMATORY AGENT; VASOCONSTRICTOR AGENT;

ABDOMINAL INFECTION; ADULT; ANTIBIOTIC THERAPY; APACHE; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; CONTINUOUS INFUSION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOUBLE BLIND PROCEDURE; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; HOSPITAL MORTALITY; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LOW DRUG DOSE; LUNG INFECTION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SKIN INFECTION; SOFT TISSUE INFECTION; TREATMENT DURATION; URINARY TRACT INFECTION; AGED; CHINA; DRUG ADMINISTRATION; EPIDEMIOLOGY; FEMALE; FLUID THERAPY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MORTALITY; PATHOPHYSIOLOGY; PROCEDURES; STATISTICS AND NUMERICAL DATA; TIME FACTOR; TREATMENT OUTCOME;

AGED; ANTI-INFLAMMATORY AGENTS; CHINA; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUID THERAPY; HOSPITAL MORTALITY; HUMANS; HYDROCORTISONE; INFUSIONS, INTRAVENOUS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; SHOCK, SEPTIC; TIME FACTORS; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 85020424441     PISSN: 07356757     EISSN: 15328171     Source Type: Journal    
DOI: 10.1016/j.ajem.2017.06.004     Document Type: Article

References (29)

1. Kimmoun, A., Ducrocq, N., Levy, B., Mechanisms of vascular hyporesponsiveness in septic shock. Curr Vasc Pharmacol 11 (2013), 139–149.
2. Russell, J.A., Walley, K.R., Gordon, A.C., Cooper, D.J., Hebert, P.C., Singer, J., et al. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. Crit Care Med 37 (2009), 811–818.
3. Kanczkowski, W., Sue, M., Zacharowski, K., Reincke, M., Bornstein, S.R., The role of adrenal gland microenvironment in the HPA axis function and dysfunction during sepsis. Mol Cell Endocrinol 408 (2015), 241–248.
4. Dellinger, R.P., Levy, M.M., Rhodes, A., Annane, D., Gerlach, H., Opal, S.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41 (2013), 580–637.
5. Marik, P.E., Pastores, S.M., Annane, D., Meduri, G.U., Sprung, C.L., Arlt, W., et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 36 (2008), 1937–1949.
6. Bruno, J.J., Dee, B.M., Anderegg, B.A., Hernandez, M., Pravinkumar, S.E., US practitioner opinions and prescribing practices regarding corticosteroid therapy for severe sepsis and septic shock. J Crit Care 27 (2012), 351–361.
7. Katsenos, C.S., Antonopoulou, A.N., Apostolidou, E.N., Ioakeimidou, A., Kalpakou, G.T., Papanikolaou, M.N., et al. Early administration of hydrocortisone replacement after the advent of septic shock: impact on survival and immune response. Crit Care Med 42 (2014), 1651–1657.
8. El-Nawawy, A., Khater, D., Omar, H., Wali, Y., Evaluation of early corticosteroid therapy in management of pediatric septic shock in pediatric intensive care patients: a randomized clinical study. Pediatr Infect Dis J 36 (2017), 155–159.
9. Park, H.Y., Suh, G.Y., Song, J.U., Yoo, H., Jo, I.J., Shin, T.G., et al. Early initiation of low-dose corticosteroid therapy in the management of septic shock: a retrospective observational study. Crit Care, 16, 2012, R3.
10. Dellinger, R.P., Levy, M.M., Rhodes, A., Annane, D., Gerlach, H., Opal, S.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39 (2013), 165–228.
11. Reinhart, K., Brunkhorst, F., Bone, H., Gerlach, H., Grundling, M., Kreymann, G., et al. Diagnosis and therapy of sepsis: guidelines of the German Sepsis Society Inc. and the German Interdisciplinary Society for Intensive and Emergency Medicine. Anaesthesist 55:Suppl. 1 (2006), 43–56.
12. Brunkhorst, F.M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358 (2008), 125–139.
13. Vincent, J.L., de Mendonca, A., Cantraine, F., Moreno, R., Takala, J., Suter, P.M., et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Crit Care Med 26 (1998), 1793–1800.
14. Sprung, C.L., Annane, D., Keh, D., Moreno, R., Singer, M., Freivogel, K., et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 358 (2008), 111–124.
15. Knaus, W.A., Draper, E.A., Wagner, D.P., Zimmerman, J.E., APACHE II: a severity of disease classification system. Crit Care Med 13 (1985), 818–829.
16. Knaus, W.A., Zimmerman, J.E., Wagner, D.P., Draper, E.A., Lawrence, D.E., APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med 9 (1981), 591–597.
17. Vincent, J.L., Moreno, R., Takala, J., Willatts, S., De Mendonca, A., Bruining, H., et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22 (1996), 707–710.
18. Annane, D., Sebille, V., Charpentier, C., Bollaert, P.E., Francois, B., Korach, J.M., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288 (2002), 862–871.
19. Volbeda, M., Wetterslev, J., Gluud, C., Zijlstra, J.G., van der Horst, I.C., Keus, F., Glucocorticosteroids for sepsis: systematic review with meta-analysis and trial sequential analysis. Intensive Care Med 41 (2015), 1220–1234.
20. Keh, D., Trips, E., Marx, G., Wirtz, S.P., Abduljawwad, E., Bercker, S., et al. Effect of hydrocortisone on development of shock among patients with severe sepsis: the HYPRESS randomized clinical trial. JAMA 316 (2016), 1775–1785.
21. Moreno, R., Sprung, C.L., Annane, D., Chevret, S., Briegel, J., Keh, D., et al. Time course of organ failure in patients with septic shock treated with hydrocortisone: results of the corticus study. Intensive Care Med 37 (2011), 1765–1772.
22. Bollaert, P.E., Charpentier, C., Levy, B., Debouverie, M., Audibert, G., Larcan, A., Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 26 (1998), 645–650.
23. Bellissant, E., Annane, D., Effect of hydrocortisone on phenylephrine—mean arterial pressure dose-response relationship in septic shock. Clin Pharmacol Ther 68 (2000), 293–303.
24. Oppert, M., Schindler, R., Husung, C., Offermann, K., Graf, K.J., Boenisch, O., et al. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med 33 (2005), 2457–2464.
25. Sligl, W.I., Milner, D.A. Jr., Sundar, S., Mphatswe, W., Majumdar, S.R., Safety and efficacy of corticosteroids for the treatment of septic shock: a systematic review and meta-analysis. Clin Infect Dis 49 (2009), 93–101.
26. Annane, D., Bellissant, E., Sebille, V., Lesieur, O., Mathieu, B., Raphael, J.C., et al. Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve. Br J Clin Pharmacol 46 (1998), 589–597.
27. Patel, G.P., Balk, R.A., Systemic steroids in severe sepsis and septic shock. Am J Respir Crit Care Med 185 (2012), 133–139.
28. De Bosscher, K., Vanden Berghe, W., Haegeman, G., Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors. J Neuroimmunol 109 (2000), 16–22.
29. Arafah, B.M., Hypothalamic pituitary adrenal function during critical illness: limitations of current assessment methods. J Clin Endocrinol Metab 91 (2006), 3725–3745.